title: Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.
abstract: The lack of proven screening tools for early detection and the high mortality of ovarian serous carcinoma (OSC), particularly high grade, have focused attention on identifying putative precursor lesions with distinct morphological and molecular characteristics. The finding of occult invasive and intraepithelial fallopian tube carcinomas in prophylactically removed specimens from asymptomatic high-risk BRCA 1/2-mutation carriers supports the notion of an origin for OSC in the fallopian tube. The intraepithelial carcinomas have been referred to as serous intraepithelial carcinomas (STICs) but our own findings (unpublished data) and recent reports have drawn attention to a spectrum of changes that fall short of STICs that we have designated serous tubal intraepithelial lesions (STILs).
authors.affiliation: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
authors.forename: Amy L
authors.initials: AL
authors.lastname: Gross
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Kurman
authors.forename: Russell
authors.initials: R
authors.lastname: Vang
authors.forename: Ie-Ming
authors.initials: IeM
authors.lastname: Shih
authors.forename: Kala
authors.initials: K
authors.lastname: Visvanathan
references.citation: Am J Pathol. 2004 May;164(5):1511-8
references.pmid: 15111296
references.citation: Am J Surg Pathol. 2007 Feb;31(2):161-9
references.pmid: 17255760
references.citation: Clin Cancer Res. 2008 Jul 1;14(13):4067-78
references.pmid: 18593983
references.citation: Cell Res. 2009 Jan;19(1):47-57
references.pmid: 19114989
references.citation: Methods Mol Biol. 2009;472:413-37
references.pmid: 19107446
references.citation: Int J Gynecol Pathol. 2002 Oct;21(4):407-11
references.pmid: 12352190
references.citation: J Pathol. 2007 Jan;211(1):26-35
references.pmid: 17117391
references.citation: J Natl Cancer Inst. 2002 Jan 2;94(1):32-8
references.pmid: 11773280
references.citation: Gynecol Oncol. 2006 Nov;103(2):719-28
references.pmid: 16698071
references.citation: Gynecol Oncol. 1983 Feb;15(1):10-7
references.pmid: 6822361
references.citation: Am J Hum Genet. 1995 Jan;56(1):265-71
references.pmid: 7825587
references.citation: J Natl Cancer Inst. 1997 Jul 2;89(13):932-8
references.pmid: 9214672
references.citation: Lancet. 2007 May 19;369(9574):1703-10
references.pmid: 17512855
references.citation: Hum Pathol. 1995 Nov;26(11):1268-74
references.pmid: 7590703
references.citation: Am J Pathol. 2006 Jul;169(1):258-67
references.pmid: 16816378
references.citation: Lancet. 1994 Mar 19;343(8899):692-5
references.pmid: 7907678
references.citation: JAMA. 2006 Jul 12;296(2):185-92
references.pmid: 16835424
references.citation: N Engl J Med. 2002 May 23;346(21):1616-22
references.pmid: 12023993
references.citation: Gynecol Oncol. 2006 Jan;100(1):58-64
references.pmid: 16137750
references.citation: Am J Epidemiol. 1983 Feb;117(2):128-39
references.pmid: 6681935
references.citation: Am J Obstet Gynecol. 2006 Jun;194(6):1702-9
references.pmid: 16731090
references.citation: Am J Surg Pathol. 2006 Feb;30(2):230-6
references.pmid: 16434898
references.citation: Int J Cancer. 2006 Sep 15;119(6):1412-8
references.pmid: 16615107
references.citation: Lancet Oncol. 2008 Dec;9(12):1191-7
references.pmid: 19038766
references.citation: Gynecol Oncol. 2002 Oct;87(1):52-6
references.pmid: 12468342
references.citation: Gynecol Oncol. 2008 Nov;111(2):226-32
references.pmid: 18718648
references.citation: Br J Cancer. 2004 Apr 19;90(8):1492-7
references.pmid: 15083174
references.citation: Hum Pathol. 1995 Nov;26(11):1260-7
references.pmid: 7590702
references.citation: Oncology (Williston Park). 1998 Jun;12(6):813-9; discussion 820, 825-6
references.pmid: 9644683
references.citation: Gynecol Oncol. 2005 May;97(2):476-82
references.pmid: 15863147
references.citation: Hum Pathol. 1999 Feb;30(2):151-7
references.pmid: 10029442
references.citation: Cancer. 2000 Jul 15;89(2):383-90
references.pmid: 10918170
references.citation: Am J Pathol. 1997 Jan;150(1):177-85
references.pmid: 9006334
references.citation: Gynecol Oncol. 2008 Sep;110(3):408-17
references.pmid: 18597838
references.citation: J Clin Oncol. 2005 Jan 1;23(1):127-32
references.pmid: 15625367
references.citation: Annu Rev Pathol. 2009;4:287-313
references.pmid: 18842102
references.citation: J Clin Oncol. 2008 Sep 1;26(25):4160-5
references.pmid: 18757330
references.citation: Lancet Oncol. 2006 Mar;7(3):223-9
references.pmid: 16510331
references.citation: Mol Oncol. 2009 Apr;3(2):97-137
references.pmid: 19383374
references.citation: Int J Gynecol Pathol. 2008 Jan;27(1):1-9
references.pmid: 18156967
references.citation: Am J Surg Pathol. 1982 Mar;6(2):93-108
references.pmid: 7102898
references.citation: J Natl Cancer Inst. 1998 Nov 18;90(22):1729-34
references.pmid: 9827528
references.citation: Mol Oncol. 2009 Apr;3(2):165-70
references.pmid: 19383378
references.citation: Gynecol Oncol. 2008 May;109(2):168-73
references.pmid: 18342932
references.citation: Am J Surg Pathol. 1992 Jun;16(6):600-10
references.pmid: 1599038
references.citation: Am J Surg Pathol. 2001 Oct;25(10):1283-9
references.pmid: 11688463
references.citation: J Clin Oncol. 2007 Sep 1;25(25):3985-90
references.pmid: 17761984
references.citation: Clin Cancer Res. 2005 Sep 1;11(17):6116-26
references.pmid: 16144910
references.citation: N Engl J Med. 2002 May 23;346(21):1609-15
references.pmid: 12023992
references.citation: Int J Gynecol Pathol. 2009 Jul;28(4):308-15
references.pmid: 19483636
references.citation: Gynecol Oncol. 2009 Oct;115(1):108-111
references.pmid: 19615727
references.citation: Int J Gynecol Pathol. 2008 Apr;27(2):151-60
references.pmid: 18317228